Visits: 2310, Avg visit time (secs): 225,83 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 879 | 38,05% | |
| /programmes.html | 393 | 17,01% |
| /efsd-jdrf-novo/efsd-jdrf-novo-rfa09.html | 263 | 11,39% |
| /msd/basic/efsd-msd-basic-rfa10.html | 204 | 8,83% |
| /amylin/efsd-amylin-rfa09.html | 56 | 2,42% |
| /efsd-jdrf-novo/efsd-jdrf-novo-rfa08.html | 54 | 2,34% |
| /msd/albert-renold/efsd-msd-arenold.html | 52 | 2,25% |
| /home.html | 45 | 1,95% |
| /sanofi-aventis/macrovascular/efsd-sanofi-aventis-mv-rfa09.html | 45 | 1,95% |
| /novo-t2/efsd-novo-t2-rfa08.html | 31 | 1,34% |
| /pfizer/efsd-pfizer-rfa09.html | 26 | 1,13% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 1025 | 44,37% |
| /amylin/efsd-amylin-rfa10.html | 219 | 9,48% |
| /lilly/programme/efsd-lilly-rfa09.html | 154 | 6,67% |
| /amylin/efsd-amylin-rfa09.html | 110 | 4,76% |
| /lilly/fellowships/efsd-lilly-fship09.html | 76 | 3,29% |
| /home.html | 56 | 2,42% |
| /msd/basic/efsd-msd-basic-rfa10.html | 52 | 2,25% |
| /gsk/efsd-gsk-rfa08.html | 42 | 1,82% |
| /sanofi-aventis/macrovascular/efsd-sanofi-aventis-mv-rfa09.html | 40 | 1,73% |
| /programmes.html | 38 | 1,65% |
| /msd/albert-renold/efsd-msd-arenold.html | 37 | 1,60% |